Steve Valiquette

Stock Analyst at Barclays

(1.44)
# 3,608
Out of 5,130 analysts
152
Total ratings
45.71%
Success rate
-3.61%
Average return

Stocks Rated by Steve Valiquette

Brookdale Senior Living
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $8$9.5
Current: $11.01
Upside: -13.71%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10$12
Current: $7.46
Upside: +60.86%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596$616
Current: $816.06
Upside: -24.52%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8$9
Current: $2.80
Upside: +221.43%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12$10
Current: $5.42
Upside: +84.50%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25$24
Current: $17.14
Upside: +40.02%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89$86
Current: $80.30
Upside: +7.10%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86$85
Current: $46.61
Upside: +82.36%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275$300
Current: $472.07
Upside: -36.45%
LTC Properties
May 3, 2023
Maintains: Underweight
Price Target: $35$34
Current: $35.48
Upside: -4.17%
Maintains: Overweight
Price Target: $70$105
Current: $201.20
Upside: -47.81%
Maintains: Overweight
Price Target: $57$55
Current: $74.90
Upside: -26.57%
Maintains: Equal-Weight
Price Target: $15$13
Current: $19.28
Upside: -32.57%
Upgrades: Equal-Weight
Price Target: $132$142
Current: $207.03
Upside: -31.41%
Maintains: Underweight
Price Target: $13$5
Current: $32.29
Upside: -84.52%
Initiates: Equal-Weight
Price Target: $57
Current: $102.93
Upside: -44.62%
Maintains: Overweight
Price Target: $78$82
Current: $186.08
Upside: -55.93%
Maintains: Overweight
Price Target: $20$18
Current: $16.71
Upside: +7.72%
Maintains: Equal-Weight
Price Target: $33$31
Current: $44.27
Upside: -29.98%
Maintains: Overweight
Price Target: $400$375
Current: $181.50
Upside: +106.61%
Maintains: Equal-Weight
Price Target: $20$19
Current: $37.33
Upside: -49.10%
Maintains: Overweight
Price Target: $500$570
Current: $276.85
Upside: +105.89%
Downgrades: Equal-Weight
Price Target: $70$64
Current: $201.11
Upside: -68.18%
Maintains: Overweight
Price Target: $275$310
Current: $278.95
Upside: +11.13%
Maintains: Overweight
Price Target: $495$565
Current: $343.98
Upside: +64.25%
Downgrades: Equal-Weight
Price Target: $150$75
Current: $2.38
Upside: +3,051.26%
Upgrades: Overweight
Price Target: $26$19
Current: $5.30
Upside: +258.49%
Maintains: Underweight
Price Target: $6$10
Current: $3.32
Upside: +201.20%
Initiates: Overweight
Price Target: $20
Current: $8.59
Upside: +132.83%
Reinstates: Overweight
Price Target: $260
Current: $96.18
Upside: +170.33%